Cargando…

Cerebrovascular reactivity in retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations

Retinal Vasculopathy with Cerebral Leukoencephalopathy and Systemic manifestations (RVCL-S) is a small vessel disease caused by TREX1 mutations. RVCL-S is characterized by retinal vasculopathy and brain white matter lesions with and without contrast enhancement. We aimed to investigate cerebrovascul...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoogeveen, Evelien S, Pelzer, Nadine, Ghariq, Eidrees, van Osch, Matthias JP, Dahan, Albert, Terwindt, Gisela M, Kruit, Mark C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7983338/
https://www.ncbi.nlm.nih.gov/pubmed/33736510
http://dx.doi.org/10.1177/0271678X20929430
_version_ 1783667885491617792
author Hoogeveen, Evelien S
Pelzer, Nadine
Ghariq, Eidrees
van Osch, Matthias JP
Dahan, Albert
Terwindt, Gisela M
Kruit, Mark C
author_facet Hoogeveen, Evelien S
Pelzer, Nadine
Ghariq, Eidrees
van Osch, Matthias JP
Dahan, Albert
Terwindt, Gisela M
Kruit, Mark C
author_sort Hoogeveen, Evelien S
collection PubMed
description Retinal Vasculopathy with Cerebral Leukoencephalopathy and Systemic manifestations (RVCL-S) is a small vessel disease caused by TREX1 mutations. RVCL-S is characterized by retinal vasculopathy and brain white matter lesions with and without contrast enhancement. We aimed to investigate cerebrovascular reactivity (CVR) in RVCL-S. In this cross-sectional observational study, 21 RVCL-S patients, 23 mutation-negative family members, and 31 healthy unrelated controls were included. CVR to a hypercapnic challenge was measured using dual-echo arterial spin labeling magnetic resonance imaging. Stratified analyses based on age were performed. We found that CVR was decreased in gray and white matter of RVCL-S patients compared with family members and healthy controls (ANCOVA; P < 0.05 for all comparisons). This was most noticeable in RVCL-S patients aged ≥40 years (ANCOVA, P < 0.05 for all comparisons). In RVCL-S patients aged < 40 years, only CVR in white matter was lower when compared to healthy controls (P < 0.05). Gray matter CVR was associated with white matter lesion volume in RVCL-S patients (r = –0.527, P = 0.01). In conclusion, impaired cerebrovascular reactivity may play an important role in the pathophysiology of RVCL-S and may be an useful early biomarker of cerebrovascular disease severity.
format Online
Article
Text
id pubmed-7983338
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-79833382021-03-31 Cerebrovascular reactivity in retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations Hoogeveen, Evelien S Pelzer, Nadine Ghariq, Eidrees van Osch, Matthias JP Dahan, Albert Terwindt, Gisela M Kruit, Mark C J Cereb Blood Flow Metab Original Articles Retinal Vasculopathy with Cerebral Leukoencephalopathy and Systemic manifestations (RVCL-S) is a small vessel disease caused by TREX1 mutations. RVCL-S is characterized by retinal vasculopathy and brain white matter lesions with and without contrast enhancement. We aimed to investigate cerebrovascular reactivity (CVR) in RVCL-S. In this cross-sectional observational study, 21 RVCL-S patients, 23 mutation-negative family members, and 31 healthy unrelated controls were included. CVR to a hypercapnic challenge was measured using dual-echo arterial spin labeling magnetic resonance imaging. Stratified analyses based on age were performed. We found that CVR was decreased in gray and white matter of RVCL-S patients compared with family members and healthy controls (ANCOVA; P < 0.05 for all comparisons). This was most noticeable in RVCL-S patients aged ≥40 years (ANCOVA, P < 0.05 for all comparisons). In RVCL-S patients aged < 40 years, only CVR in white matter was lower when compared to healthy controls (P < 0.05). Gray matter CVR was associated with white matter lesion volume in RVCL-S patients (r = –0.527, P = 0.01). In conclusion, impaired cerebrovascular reactivity may play an important role in the pathophysiology of RVCL-S and may be an useful early biomarker of cerebrovascular disease severity. SAGE Publications 2020-06-17 2021-04 /pmc/articles/PMC7983338/ /pubmed/33736510 http://dx.doi.org/10.1177/0271678X20929430 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Articles
Hoogeveen, Evelien S
Pelzer, Nadine
Ghariq, Eidrees
van Osch, Matthias JP
Dahan, Albert
Terwindt, Gisela M
Kruit, Mark C
Cerebrovascular reactivity in retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations
title Cerebrovascular reactivity in retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations
title_full Cerebrovascular reactivity in retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations
title_fullStr Cerebrovascular reactivity in retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations
title_full_unstemmed Cerebrovascular reactivity in retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations
title_short Cerebrovascular reactivity in retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations
title_sort cerebrovascular reactivity in retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7983338/
https://www.ncbi.nlm.nih.gov/pubmed/33736510
http://dx.doi.org/10.1177/0271678X20929430
work_keys_str_mv AT hoogeveeneveliens cerebrovascularreactivityinretinalvasculopathywithcerebralleukoencephalopathyandsystemicmanifestations
AT pelzernadine cerebrovascularreactivityinretinalvasculopathywithcerebralleukoencephalopathyandsystemicmanifestations
AT ghariqeidrees cerebrovascularreactivityinretinalvasculopathywithcerebralleukoencephalopathyandsystemicmanifestations
AT vanoschmatthiasjp cerebrovascularreactivityinretinalvasculopathywithcerebralleukoencephalopathyandsystemicmanifestations
AT dahanalbert cerebrovascularreactivityinretinalvasculopathywithcerebralleukoencephalopathyandsystemicmanifestations
AT terwindtgiselam cerebrovascularreactivityinretinalvasculopathywithcerebralleukoencephalopathyandsystemicmanifestations
AT kruitmarkc cerebrovascularreactivityinretinalvasculopathywithcerebralleukoencephalopathyandsystemicmanifestations